1 day Ago
Suspense crime, Digital Desk : The drug Mounjaro (tirzepatide) has been all the buzz ever since it was released in India, a country which did not have access to it before. This comes after its prompter acquisition in America, which facilitated it in controlling diabetes and aiding in weight loss. As highlighted in Pharmarack data, interests from both patients and doctors alike is evident in India as four thousand injections were sold in the first ten days of its launch.
Appetite suppresion, a decrease in food and sugar cravings, improved control over the will to snack and, as side effects, bloating and blue stools have had the most reporting by patients so far. Dosage: Administered weekly. Uniquely, every patient must submit their consumption of Mounjaro at the end of each month.
Below is the cost structure: Vial 5 mg costs ₹4,375. Vial 2.5 mg is charged at ₹3,500.
Based on the dosage, expenses shift between ₹14,000 and ₹17,500 each month, although experts recommend tightly paced monthly reductions. Mounjaro imitates the functioning of two natural hormones GIP (Gastric Inhibitory Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) Mounjaro is said to enable better control of diabetes and aid in shredding weight for Mounjaro users. Side effects include but are not limited to: Constipation Accompanied by dull nausea Bloating Blue Bleeding Dr.
Sweta Budyal, an endocrinology and diabetology specialist at Fortis Hospital Mulund told: “Using low starting doses with slow incrementation results in less of these symptoms. The medication has side effects that caused a few patients to discontinue, but most have adjusted to it by now. Blood sugar improvements are typically seen within 1-2 weeks, whereas significant weight loss commences between 4-6 weeks and becomes pronounced in 3-6 months.
Some patients have reported a 10-15% reduction in body weight over time, thanks to lifestyle changes and dieting. Control Over Blood Sugar Levels Mounjaro enhances control over fasting and post meal glucose levels, which improves a short time into therapy. Apar its potency, physicians will tend to dial back other diabetes medications for fear of hypoglycemia.
Down at Fortis C-DOC Hospital, Executive Chairman Dr. Anoop Misra mentions that none of his 25 patients have stopped Mounjaro, and all have claimed significant weight loss after 3-4 weeks. Mounjaro Versus Ozempic: Which Is Better? When comparing clinical results, Mounjaro beats semaglutide by a landslide when it comes to weight loss, claiming it happens both faster and in greater amounts: Users of Mounjaro (10-15mg doses) managed a 5% body weight reduction in roughly 12 weeks.
Users of Ozempic (1mg) needed around 24 weeks to achieve the same outcome. As noted by Hrishikesh Salgaonkar from Fortis Hospital Mulund, SURPASS clinical trials results show that participants using Mounjaro lost 11.2 kg on average in 28 weeks, while participants using metering semaglutide lost only 6.
9 kg. Therefore, Mounjaro proves to be more effective and quicker in yielding results in weight loss and controlling diabetes. Read More: Why Additive-Free Eating Is Becoming Essential for Better Health.
